Mark S. Levine - 26 Jan 2023 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Legal Officer
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Mark S. Levine
Issuer symbol: IMVT
Transactions as of: 26 Jan 2023
Net transactions value: -$187,988
Form type: 4
Filing time: 27 Jan 2023, 06:20:19 UTC
Previous filing: 19 Aug 2022
Next filing: 14 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	$187,988	-10,156	-4%	$18.51	245,660	26 Jan 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 28, 2022, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on January 31, 2022, of which 35,750 of these RSUs vested on January 19, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Content

On January 28, 2022, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on January 31, 2022, of which 35,750 of these RSUs vested on January 19, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.